Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coagulation factor II, commonly known as prothrombin, is a vital plasma glycoprotein involved in the blood coagulation cascade. It serves as the precursor to thrombin, an enzyme that plays a central role in converting fibrinogen into fibrin during clot formation. Prothrombin is encoded by the F2 gene and synthesized primarily in the liver. Upon vascular injury, it is activated by the prothrombinase complex (composed of factor Xa and cofactor Va), which cleaves prothrombin to generate active thrombin. Thrombin catalyzes the conversion of fibrinogen to insoluble fibrin, activation of factors V, VII, VIII, XIII and platelet activation.
Anticoagulation through inhibition of thrombin generation or activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coagulation Factor II (Prothrombin).